Applied Therapeutics, Inc. (NASDAQ: APLT) reported Q3 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Applied Therapeutics, Inc. (APLT) click here.